CW (NYSE) insider sells: 3,105 shares from vested performance award disclosed

Rhea-AI Filing Summary

The issuer filed a Form 144 disclosing proposed sales of Common stock totaling 3,105 shares tied to a performance share vesting event dated 02/03/2026, with UBS Financial Services Inc. listed as broker. The filing also reports prior dispositions by K. Christopher Farkas: 5,047 shares on 11/11/2025 for $2,916,721.36 and 2,665 shares on 02/04/2026 for $1,669,034.61.

Insights

Securities Compliance Analyst

Form 144 reports officer/entity sales and a planned sale tied to vested performance shares.

The filing lists a planned disposition of 3,105 common shares from a performance share vesting on 02/03/2026, with UBS Financial Services Inc. named as the broker. Prior dispositions by K. Christopher Farkas are recorded with exact share counts and aggregate proceeds.

These notices satisfy reporting rules; cash‑flow treatment and any limits on sale methods are not detailed in the excerpt. Subsequent filings or broker statements would show execution details and timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3105	2144623.50	36869530	02/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/03/2026	Performance share vesting	Issuer			3105	02/03/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
K. Christopher Farkas 130 Harbour Place Drive Suite 300 Davidson NC 28036	Common	11/11/2025	5047	2916721.36
K. Christopher Farkas 130 Harbour Place Drive Suite 300 Davidson NC 28036	Common	02/04/2026	2665	1669034.61

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CW's Form 144 disclose about planned sales?

The Form 144 discloses a planned sale of 3,105 common shares tied to a performance share vesting dated 02/03/2026, with UBS Financial Services Inc. listed as broker.

Who reported recent share sales in the filing for CW?

K. Christopher Farkas reported dispositions of 5,047 shares on 11/11/2025 for $2,916,721.36 and 2,665 shares on 02/04/2026 for $1,669,034.61.

Are the sales in the Form 144 linked to equity awards?

Yes; the filing shows the 3,105 shares to be sold are from a performance share vesting event dated 02/03/2026, indicating award-related origin of the shares.

Which broker is named for the planned transaction in CW's Form 144?

The broker listed for the planned sale is UBS Financial Services Inc, with address shown as 1000 Harbor Blvd, Weehawken, NJ in the excerpt.